Sodium-Glucose Cotransporter-2 inhibitors utilization and outcomes in patients with chronic kidney disease at a tertiary centre
Sodium-glucose cotransporter-2 (SGLT2) inhibitor is an antidiabetic agent with cardiac and renal protective properties. Its renal protective property is a result of the inhibition of tubular sodium reabsorption and reduction in the intraglomerular pressure. The use of SGLT2 inhibitor in chronic kidn...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Penerbit UKM
2023
|
| Online Access: | http://journalarticle.ukm.my/24393/1/MH_5pdf_.pdf http://journalarticle.ukm.my/24393/ https://medicineandhealthukm.com/sites/medicineandhealthukm.com/files/article/2023/5_ms0682_pdf_19143.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|